scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano1, Mohsen Naghavi1, Kyle J Foreman2, Stephen S Lim1  +192 moreInstitutions (95)
15 Dec 2012-The Lancet (Elsevier)-Vol. 380, Iss: 9859, pp 2095-2128
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex, using the Cause of Death Ensemble model.
About: This article is published in The Lancet.The article was published on 2012-12-15 and is currently open access. It has received 11809 citations till now. The article focuses on the topics: Mortality rate & Years of potential life lost.

Summary (6 min read)

Introduction

  • Cause-specific mortality is arguably one of the most fundamental metrics of population health.
  • For the remaining deaths which are not medically certified, many different data sources and diagnostic approaches must be used from surveillance systems, demographic research sites, surveys, censuses, disease registries, and police records to construct a consolidated picture of causes of death in various populations.
  • These efforts often include very specific steps undertaken for different data sources and are frequently poorly documented.
  • GBD revisions for 1999, 2000, 2001, 2002, 2004, and 2008 have used these compositional models to allocate deaths according to three broad cause groups: communicable, maternal, neonatal, and nutritional causes; noncommunicable diseases; and injuries.
  • 38 Given the profusion of statistical modeling options, an important innovation has been the reporting of out-of-sample predictive validity to document the performance of complex models.

Data and methods

  • Some general aspects of the analytical framework such as the creation of the 21 GBD regions and the full hierarchical cause list including the mapping of the International Classification of Diseases and Injuries (ICD) to the GBD cause list are reported elsewhere.
  • While results are reported in this paper at the regional level for 1990 and 2010, the cause of death analysis has been undertaken at the country level for 187 countries from 1980 to 2010.
  • Using longer time series improves the performance of many types of estimation models; data prior to 1980, however, are much sparser for developing countries so the authors have restricted the analysis to 1980-2010.

Database development

  • Over the five year duration of the GBD 2010 study, the authors have sought to identify all published and unpublished data sources relevant to estimating causes of death for 187 countries from 1980 to 2010.
  • Web Table 1a provides a summary of the siteyears of data identified by broad type of data system and, similarly, Web Table 1b illustrates the number of site-years by GBD region.
  • Of the GBD regions, subSaharan Africa Central has the most limited evidence base with data on only 27 causes from at least one country.
  • In addition, there is country to country variation in the detail used to report causes of death included in national reporting lists, namely the basic tabulation list for ICD9, the ICD10 tabulation list, three digit and four digit detail, and special reporting lists.
  • Verbal autopsy data collected through sample registration systems, demographic surveillance systems, or surveys Verbal autopsy (VA) is a means for ascertaining the cause of death of individuals and the cause-specific mortality fractions in populations with incomplete vital registration systems.

Population-based cancer registries

  • Population-based cancer registries provide an important source of data on incidence of cancers in various countries.
  • The authors identified 2,715 site-years of cancer registry data across 93 countries.
  • The log of the MI ratio has been estimated as a function of national income per capita with random effects for country, year, and age.
  • The estimated mortality to incidence ratios have been used to map cancer registry data on incidence to expected deaths which have been incorporated into the database.
  • MI ratios by country, age, and sex are available on request.

Police reports

  • In most countries, police and crime reports are an important source of information for some types of injuries, notably road injuries and inter-personal violence.
  • The police reports used in this analysis were collected from published studies, national agencies, and institutional surveys such as the United Nations Crime Trends survey and the WHO Global Status Report on Road Safety Survey.30,41.
  • The authors identified 32 site-years of burial and mortuary data in 11 countries from ministries of health, published reports, and mortuaries themselves.
  • The authors also identified 52 surveys/censuses covering injury mortality across 65 survey/census years.
  • Surveillance data on the number of maternal deaths, or the maternal mortality ratio multiplied by births, were converted into cause fractions by dividing by the total number of deaths estimated in the reproductive age groups.

Health facility data

  • The authors chose to only incorporate deaths due to injury from this source because of known bias.
  • In settings where a data source does not capture all deaths in a population, the cause composition of deaths captured may be different than those that are not.
  • At the global level, the number of deaths estimated in 2010 for ARI and diarrhea for example differ by 0·9% and 1·2%, respectively, between models that include all data and those that exclude data where under-five death registration is below 70% complete.
  • Garbage codes are causes of death that should not be identified as underlying causes of death but have been entered as the underlying cause of death on death certificates.
  • For the GBD 2010, the authors have identified causes that should not be assigned as underlying cause of death at a much more detailed level.

Cause of Death Ensemble modeling (CODEm)

  • For all major causes of death except for HIV/AIDS and measles, the authors have used cause of death ensemble modeling – 133 causes in the cause list and three other special aggregates.
  • In addition, four families of statistical models are developed using covariates: mixed effects linear models of the log of the death rate, mixed effects linear models of the logit of the cause fraction, spatial-temporal Gaussian process regression (ST-GPR) models of the log of the death rate, and ST-GPR of the logit of the cause fraction.
  • 3) Based on out-of-sample predictive validity, the best performing model or ensemble is selected.
  • Web Table 6 summarizes the performance of the CODEm models developed for 133 causes in the cause list for which the authors exclusively use CODEm and three special aggregates in the GBD 2010.
  • In all cases the out-of-sample performance is worse (larger RMSE) than the in-sample performance.

Negative binomial models

  • For 13 causes, the number of deaths observed in the database is too low to generate stable estimates of out-of-sample predictive validity.
  • For these causes, the authors developed negative binomial models using plausible covariates.
  • These causes are identified in Web Table 5.
  • For these negative binomial models, standard model building practice was followed where plausible covariates were included in the model development and reverse stepwise procedures followed for covariate inclusion.
  • Uncertainty distributions were estimated using both uncertainty in the regression betas for the covariates and from the gamma distribution of the negative binomial.

Fixed proportion models

  • In 28 cases where death is a rare event, the authors have first modeled the parent cause in the GBD hierarchy using CODEm and then allocated deaths to specific causes using a fixed proportion.
  • Proportions have been computed using all available data in the database and are fixed over time, but, depending on data density, allowed to vary by region, age, or sex.
  • Finally, cellulitis, decubitus ulcer, other skin and subcutaneous diseases, abscess, impetigo, and other bacterial skin diseases all varied by age and sex.
  • The meta-regression have generated region-age-sex estimates with uncertainty of etiological fractions for diarrhea, LRI, meningitis, chronic kidney disease, maternal conditions, cirrhosis.
  • In the cases of cirrhosis, liver cancer, maternal conditions, and chronic kidney disease, the studies or datasets on etiology identify primary cause as assessed clinically; for diarrhea, LRI, and meningitis, etiology is based on laboratory findings.

Natural History Models

  • For a few selected causes, there is evidence that cause of death data systems do not capture sufficient information for one of two reasons.
  • Second, there are reasons to believe that there is systematic misclassification of deaths in cause of death data sources, particularly for congenital syphilis,54,55 whooping cough,56 measles,57 and HIV/AIDS.58.
  • In the case of HIV/AIDS, a hybrid approach has been used.
  • For 36 countries, with complete and high quality vital registration systems, the authors have used CODEm, in consultation with UNAIDS.
  • For the remaining countries, the authors have used the estimates with uncertainty by age and sex provided directly by UNAIDS based on their 2012 revision.

Mortality Shock Regressions

  • To estimate deaths directly due to natural disasters or collective violence, the authors use a different approach.
  • Details of this approach are outlined in Murray et al.59.
  • To develop the covariate on battle deaths during collective violence, the authors used data from the Armed Conflict Database from the International Institute for Strategic Studies (1997-2011), the Uppsala Conflict Data Program(UCDP)/PRIO Armed Conflict Dataset (1946-present), and available data from complete VR systems.
  • The relationships between under-five mortality and adult mortality and the disaster and collective violence covariates are estimated using 43 empirical observations for disasters and 206 empirical observations for collective violence (only years with over 1 per 10,000 crude death rate from shocks are kept in this analysis).
  • The relationship is estimated for excess mortality from these data sources by first subtracting from observed mortality rates the expected death rates in shock years using the methods outlined in Murray et al.59.

Combining Results for Individual Causes of Death to Generate Final Estimates

  • Given that the authors develop single cause models, it is imperative as a final step to ensure that individual cause estimates sum to the all-cause mortality estimate for each age-sex-country-year group.
  • The authors use a simple algorithm called CoDCorrect; at the level of each draw from the posterior distribution of each cause, they proportionately rescale each cause such that the sum of the cause-specific estimates equals the number of deaths from all causes generated from the demographic analysis.47.
  • The authors have chosen levels for each cause based on consideration of the amount and quality of available data.
  • Because there are substantially more data on all cardiovascular causes from verbal autopsy studies than for specific cardiovascular causes, the authors have designated “all cardiovascular” as a level 1 cause for CoDCorrect.

Ranking lists

  • For the presentation of leading causes of death, the level at which one ranks causes is subject to debate.
  • Given the GBD cause list tree structure, multiple options are possible such as all cancers versus sitespecific cancers.
  • The authors have opted to produce tables of rankings using the level of disaggregation that seems most relevant for public health decision-making.
  • The reference standard has been constructed using the lowest observed death rate in each age group across countries with a population greater than five million (see Murray et al39 for details).
  • Because the all-cause mortality analysis is undertaken, however, for more detailed age-groups up to age 110, the authors are able to take into account the mean age of death over 80 in each country-year-sex group in computing YLLs.

Epidemiological Factors

  • To help understand the drivers of change in the numbers of deaths by cause or region, the authors have decomposed change from 1990 to 2010 into growth in total population, change in population age- and sex-structure, and change in age- and sex-specific rates.
  • The difference between 2010 deaths and the population growth and aging scenario is the difference in death numbers due to epidemiological change in age- and sex-specific death rates.
  • Each of these three differences is also presented as a percent change with reference to the 1990 observed death number.
  • Further details on the data and methods used for specific causes of death is available on request.

Global Causes of Death

  • The GBD cause list divides causes into three broad groups.
  • With declining age-specific death rates from all three groups of causes, including noncommunicable diseases, the global shift towards noncommunicable diseases and injuries as leading causes of death is being driven by population growth and aging, and not by increases in age-sex-cause specific death rates.
  • Among communicable diseases, notably lower respiratory infections (194 thousand), diarrhea (77 thousand) and meningitis (46 thousand) account for the remaining neonatal deaths.
  • A number of causes have much larger uncertainty intervals than adjacent causes in the rank list.
  • At both time periods, there is substantial variation across regions in the relative importance of different causes, with communicable diseases and related causes being much more important in parts of sub-Saharan Africa and parts of Asia than in North Africa, and vascular diseases and cancer predominating in most other regions.

Discussion

  • The GBD 2010 is the most comprehensive and systematic analysis of causes of death undertaken to date.
  • The global health community can now draw on annual estimates of mortality, by age and sex, for 21 regions of the world, for each year from 1980 to 2010, for 235 separate causes, each with 95% uncertainty intervals to aid interpretation.
  • An innovative dimension of the GBD 2010 has been the addition of estimates of deaths due to different diarrhea and lower respiratory infection (LRI) pathogens.
  • First, cause of death data even in settings with medical certification may not always accurately capture the underlying cause of death.

Author Contributions

  • CJLM, ADL, and RL prepared the first draft.
  • RL, MN, KF, SL, KS, ADL, and CJLM finalized the draft based on comments from other authors and reviewer feedback.
  • ADL and CJLM conceived of the study and provided overall guidance.
  • All other authors developed cause-specific models, reviewed results, provided guidance on the selection of key covariates, and reviewed the manuscript.

Figures and Tables

  • Decomposition analysis of the change of global death numbers by broad cause groups from 1990 to 2010 into total population growth, population aging and changes in age-,sex-and cause-specific death rates.
  • Percentage of global deaths for females and males in 1990 and 2010 by cause and age.
  • The colors represent the various level one causes; blue is for non-communicable diseases, red is for communicable, maternal, neonatal and nutritional conditions, and green is for injuries.
  • The dashed lines signify descending order in rank, while the solid lines signify ascending order in rank.
  • Some cause abbreviations used in the figure are lower respiratory infections (“LRI”); ischemic heart disease (“IHD”); chronic obstructive pulmonary disorder (“COPD”); protein energy malnutrition (“PEM”); tuberculosis (“TB”); neonatal encephalopathy (“N Enceph”); neonatal sepsis (“N Sepsis”); road injuries (“Road Inj”); cancer (“CA”); and chronic kidney disease (“CKD”).

70 Bates M, O’Grady J, Mudenda V, Shibemba A, Zumla A. New global estimates of malaria deaths.

  • Global Enterics Mutli-Center Study (GEMS): University of Maryland School of Medicine.
  • Differences in the etiology of communityacquired pneumonia according to site of care: A population-based study.
  • Respiratory syncytial virus infection in elderly and high-risk adults.
  • Lancet 2011; 377: 1438–47. 92 Beaglehole R, Yach D. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults.
  • Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets.

Did you find this useful? Give us your feedback

Citations
More filters
Journal ArticleDOI
TL;DR: There is potential for mHealth tools to better facilitate adherence to chronic disease management, but the evidence supporting its current effectiveness is mixed.
Abstract: Background: Adherence to chronic disease management is critical to achieving improved health outcomes, quality of life, and cost-effective health care. As the burden of chronic diseases continues to grow globally, so does the impact of non-adherence. Mobile technologies are increasingly being used in health care and public health practice (mHealth) for patient communication, monitoring, and education, and to facilitate adherence to chronic diseases management. Objective: We conducted a systematic review of the literature to evaluate the effectiveness of mHealth in supporting the adherence of patients to chronic diseases management (“mAdherence”), and the usability, feasibility, and acceptability of mAdherence tools and platforms in chronic disease management among patients and health care providers. Methods: We searched PubMed, Embase, and EBSCO databases for studies that assessed the role of mAdherence in chronic disease management of diabetes mellitus, cardiovascular disease, and chronic lung diseases from 1980 through May 2014. Outcomes of interest included effect of mHealth on patient adherence to chronic diseases management, disease-specific clinical outcomes after intervention, and the usability, feasibility, and acceptability of mAdherence tools and platforms in chronic disease management among target end-users. Results: In all, 107 articles met all inclusion criteria. Short message service was the most commonly used mAdherence tool in 40.2% (43/107) of studies. Usability, feasibility, and acceptability or patient preferences for mAdherence interventions were assessed in 57.9% (62/107) of studies and found to be generally high. A total of 27 studies employed randomized controlled trial (RCT) methods to assess impact on adherence behaviors, and significant improvements were observed in 15 of those studies (56%). Of the 41 RCTs that measured effects on disease-specific clinical outcomes, significant improvements between groups were reported in 16 studies (39%). Conclusions: There is potential for mHealth tools to better facilitate adherence to chronic disease management, but the evidence supporting its current effectiveness is mixed. Further research should focus on understanding and improving how mHealth tools can overcome specific barriers to adherence. [J Med Internet Res 2015;17(2):e52]

799 citations

Journal ArticleDOI
TL;DR: It is found that the impacts of dietary changes toward less meat and more plant-based diets vary greatly among regions, and the largest absolute environmental and health benefits result from diet shifts in developing countries whereas Western high-income and middle-income countries gain most in per capita terms.
Abstract: What we eat greatly influences our personal health and the environment we all share. Recent analyses have highlighted the likely dual health and environmental benefits of reducing the fraction of animal-sourced foods in our diets. Here, we couple for the first time, to our knowledge, a region-specific global health model based on dietary and weight-related risk factors with emissions accounting and economic valuation modules to quantify the linked health and environmental consequences of dietary changes. We find that the impacts of dietary changes toward less meat and more plant-based diets vary greatly among regions. The largest absolute environmental and health benefits result from diet shifts in developing countries whereas Western high-income and middle-income countries gain most in per capita terms. Transitioning toward more plant-based diets that are in line with standard dietary guidelines could reduce global mortality by 6–10% and food-related greenhouse gas emissions by 29–70% compared with a reference scenario in 2050. We find that the monetized value of the improvements in health would be comparable with, or exceed, the value of the environmental benefits although the exact valuation method used considerably affects the estimated amounts. Overall, we estimate the economic benefits of improving diets to be 1–31 trillion US dollars, which is equivalent to 0.4–13% of global gross domestic product (GDP) in 2050. However, significant changes in the global food system would be necessary for regional diets to match the dietary patterns studied here.

755 citations

Journal ArticleDOI
01 Nov 2013-Science
TL;DR: A viral antigen is sought that provides greater protection than currently available vaccines and focused on antigenic site Ø, a metastable site specific to the prefusion state of the RSV fusion (F) glycoprotein, as this site is targeted by extremely potent RSV-neutralizing antibodies.
Abstract: Respiratory syncytial virus (RSV) is the leading cause of hospitalization for children under 5 years of age. We sought to engineer a viral antigen that provides greater protection than currently available vaccines and focused on antigenic site O, a metastable site specific to the prefusion state of the RSV fusion (F) glycoprotein, as this site is targeted by extremely potent RSV-neutralizing antibodies. Structure-based design yielded stabilized versions of RSV F that maintained antigenic site O when exposed to extremes of pH, osmolality, and temperature. Six RSV F crystal structures provided atomic-level data on how introduced cysteine residues and filled hydrophobic cavities improved stability. Immunization with site O–stabilized variants of RSV F in mice and macaques elicited levels of RSV-specific neutralizing activity many times the protective threshold.

749 citations

Journal ArticleDOI
TL;DR: A high and growing prevalence of COPD is suggested, both globally and regionally, and there is a need for governments, policy makers and international organizations to consider strengthening collaborations to address COPD globally.
Abstract: In a follow–up to the 2011 United Nations (UN) high level political declaration on non-communicable diseases (NCDs) [1], the World Health Assembly, in 2012, endorsed a new health goal (the “25 by 25 goal”), which focuses on reduction of premature deaths from COPD and other NCDs by 25% by the year 2025 [2]. Despite this initiative, experts have reported that COPD remains a growing [3], but neglected global epidemic [4]. The World Health Organization (WHO) estimated that there were about 62 million people with moderate to severe COPD in 2002, with the total number of COPD cases predicted to increase to about 200 million in 2010 [5,6]. According to the 2010 Global Burden of Disease (GBD) study, COPD was responsible for about 5% of global disability–adjusted life years – DALYs (76.7 million) – and 5% of total deaths (2.9 million) [7,8]. COPD is currently rated the fourth most common specific cause of death globally and predicted to be the third by 2030, in the absence of interventions that address the risks – especially tobacco smoking, exposures to combustion products of biomass fuels and environmental pollution [9,10]. The burden of COPD has been reported to be high in some high–income countries (HIC), particularly due to high prevalence of smoking in these settings [11]. For example, between years 2000 and 2010, about 4%–10% of adults were diagnosed with non–reversible and progressive airway obstruction (a basic feature of COPD) in population–based surveys across many European countries, with smoking indicated as a major risk [12]. The WHO has estimated that in many HIC up to 73% of COPD deaths are related to tobacco smoking [6]. The European Union (EU) reported that the direct cost from COPD was over 38.6 billion Euros in 2005, representing about 3% of total health care expenditure [13,14]. In the United States (US), over 2.7 million adults were estimated to have COPD in 2011, with about 135 000 deaths reported [15]. In 2010, the US government spent nearly US$ 49.9 billion on COPD, including 29.5 billion spent on direct health care, 8.0 billion on indirect morbidity and 12.4 billion on indirect mortality costs, respectively [15]. Meanwhile, it has been estimated that despite a high prevalence of COPD in some HIC, 90% of COPD deaths still occur in low– and middle–income countries (LMIC)in the future [4] and 40% of these deaths are attributable to smoking [6]. The burden in LMIC has been comparatively high owing to relatively low COPD awareness, challenges with COPD diagnosis and increased exposures to additional risk factors, especially combustion products of biomass fuels [16]. Salvi and colleagues reported that about 3 billion people globally are exposed to smoke from biomass fuel, compared to 1 billion people who smoke tobacco globally [17]. In many developing countries COPD is neglected by governments, physicians, experts and the pharmaceutical industry, although it's been identified as an important public health problem [4]. In the last two decades, the Burden of Obstructive Lung Disease (BOLD) initiative has been collecting country–specific data on the prevalence, risk factors and socioeconomic burden of COPD, using standardized and tested methods for conducting COPD surveys in the general population [18]. This is expected to provide governments of many nations with country–specific evidence on which to develop policy on COPD prevention and management [18]. As noted above, this initiative is yet to take a full effect in many LMIC [19]. In addition, spirometry (the gold standard for COPD diagnosis) is not widely available in many LMIC [16]. Even when it is there, professionals in LMIC are often not being trained properly on how to use spirometers or interpret spirometry results. There is concern that COPD burden has been underestimated, owing to over–reliance on doctor’s diagnosis, with many diagnoses not being based on spirometry and international diagnostic guidelines [20]. The lack of routine COPD data collation and effective health information management system in many LMIC also implies that these settings could have been grossly under–represented in global burden of COPD estimates [11]. Some global and regional estimates of COPD burden have been published [1,21–23]. However, despite the fact that COPD is now prevalent in both HIC and LMIC, experts have raised concerns that reliable estimates of COPD prevalence are still few in many parts of the world. Moreover, many of the estimates are based on varying definitions and diagnostic criteria of COPD [9]. Also, some of the current estimates were reported before the BOLD surveys in several countries, thereby failing to account for the additional spirometry–based epidemiological data from the BOLD surveys. There is a need for a revised and updated estimate of COPD prevalence across world regions. We conducted a systematic review of COPD prevalence based on spirometry data across world regions. Our aim was to provide global and regional prevalence rates of COPD that could facilitate adequate policy response in these regions.

746 citations

Journal ArticleDOI
TL;DR: Major advances in the understanding of the cellular mechanisms that regulate the protein balance in muscle include the identification of several cytokines, particularly myostatin, and a common transcriptional programme that promotes muscle wasting.
Abstract: Atrophy occurs in specific muscles with inactivity (for example, during plaster cast immobilization) or denervation (for example, in patients with spinal cord injuries). Muscle wasting occurs systemically in older people (a condition known as sarcopenia); as a physiological response to fasting or malnutrition; and in many diseases, including chronic obstructive pulmonary disorder, cancer-associated cachexia, diabetes, renal failure, cardiac failure, Cushing syndrome, sepsis, burns and trauma. The rapid loss of muscle mass and strength primarily results from excessive protein breakdown, which is often accompanied by reduced protein synthesis. This loss of muscle function can lead to reduced quality of life, increased morbidity and mortality. Exercise is the only accepted approach to prevent or slow atrophy. However, several promising therapeutic agents are in development, and major advances in our understanding of the cellular mechanisms that regulate the protein balance in muscle include the identification of several cytokines, particularly myostatin, and a common transcriptional programme that promotes muscle wasting. Here, we discuss these new insights and the rationally designed therapies that are emerging to combat muscle wasting.

741 citations

References
More filters
Journal ArticleDOI
TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Abstract: Estimates of the worldwide incidence and mortality from 27 cancers in 2008 have been prepared for 182 countries as part of the GLOBOCAN series published by the International Agency for Research on Cancer. In this article, we present the results for 20 world regions, summarizing the global patterns for the eight most common cancers. Overall, an estimated 12.7 million new cancer cases and 7.6 million cancer deaths occur in 2008, with 56% of new cancer cases and 63% of the cancer deaths occurring in the less developed regions of the world. The most commonly diagnosed cancers worldwide are lung (1.61 million, 12.7% of the total), breast (1.38 million, 10.9%) and colorectal cancers (1.23 million, 9.7%). The most common causes of cancer death are lung cancer (1.38 million, 18.2% of the total), stomach cancer (738,000 deaths, 9.7%) and liver cancer (696,000 deaths, 9.2%). Cancer is neither rare anywhere in the world, nor mainly confined to high-resource countries. Striking differences in the patterns of cancer from region to region are observed.

21,040 citations

Journal ArticleDOI
TL;DR: The longitudinal glomerular filtration rate was estimated among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation.
Abstract: Background End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined. Methods We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization. Results The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m2 of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m2 (95 percent confidence interval, 1....

9,642 citations

Journal ArticleDOI
Stephen S Lim1, Theo Vos, Abraham D. Flaxman1, Goodarz Danaei2  +207 moreInstitutions (92)
TL;DR: In this paper, the authors estimated deaths and disability-adjusted life years (DALYs; sum of years lived with disability [YLD] and years of life lost [YLL]) attributable to the independent effects of 67 risk factors and clusters of risk factors for 21 regions in 1990 and 2010.

9,324 citations

Book
01 Jan 1996
TL;DR: This is the first in a planned series of 10 volumes that will attempt to "summarize epidemiological knowledge about all major conditions and most risk factors" and use historical trends in main determinants to project mortality and disease burden forward to 2020.
Abstract: This is the first in a planned series of 10 volumes that will attempt to "summarize epidemiological knowledge about all major conditions and most risk factors;...generate assessments of numbers of deaths by cause that are consistent with the total numbers of deaths by age sex and region provided by demographers;...provide methodologies for and assessments of aggregate disease burden that combine--into the Disability-Adjusted Life Year or DALY measure--burden from premature mortality with that from living with disability; and...use historical trends in main determinants to project mortality and disease burden forward to 2020." This first volume includes chapters summarizing results from the project as a whole. (EXCERPT)

7,154 citations

Related Papers (5)
Frequently Asked Questions (15)
Q1. What have the authors contributed in "Global and regional mortality from 235 causes of death for 20 age- groups in 1990 and 2010: a systematic analysis" ?

In this paper, the authors proposed a method to provide timely and accurate information on causes of death by age and sex. 

Improved estimation of mortality from HIV/AIDS including uncertainty in the future will come both from continued progress in the estimation of the time course of the HIV epidemic by UNAIDS as well as further data on the levels of adult mortality in some key countries such as Nigeria. These are important both for the prioritization of existing treatments, such as rotavirus or pneumococcal vaccines, but also for the development of future technologies. When large multi-center studies such as GEMS publish their results this will be an important addition to the analysis ; future revisions of the GBD should make use of these results as they become available. The authors believe that for causes where the magnitude of these corrections is comparatively large, future research should be targeted to trying to build a better understanding of the strengths and weaknesses of the various data sources, whether epidemiological or demographic. 

Because of known bias in the epidemiological composition of burial and mortuary data, the authors only use information on the fraction of injuries due to specific sub-causes from these sources. 

Much could be learned about causes of death in countries where death certification is poor through the more widespread testing and application of recent advances in verbal autopsy methods which greatly reduce heterogeneity in diagnostic practices across populations where VA is currently used. 

By the post-neonatal period, causes of death are dominated by diarrhea, LRI, and other infectious diseases such as measles, among others. 

Because of the variety of data sources and their associated biases, cause of death assessments are inherently uncertain and subject to vigorous debate. 

The ambition to estimate mortality from 235 causes with uncertainty for 187 countries over time from 1980 to 2010 means that many choices about data sources, quality adjustments to data and modeling strategies had to be made. 

Although the authors report more disaggregated causes, because of considerations related to public health programs, the authors have chosen to include diarrheal diseases, lower respiratory infections, maternal causes, cerebrovascular disease, liver cancer, cirrhosis, drug use, road injury, exposure to mechanical forces, animal contact, homicide, and congenital causes in the ranking list. 

In addition, four families of statistical models are developed using covariates: mixed effects linear models of the log of the death rate, mixed effects linear models of the logit of the cause fraction, spatial-temporal Gaussian process regression (ST-GPR) models of the log of the death rate, and ST-GPR of the logit of the cause fraction. 

60–62The relationships between under-five mortality and adult mortality and the disaster and collective violence covariates are estimated using 43 empirical observations for disasters and 206 empirical observations for collective violence (only years with over 1 per 10,000 crude death rate from shocks are kept in this analysis). 

For 13 causes, the number of deaths observed in the database is too low to generate stable estimates of out-of-sample predictive validity. 

Opportunities for strengthening death registration, cause of death certification, and the more widespread use of verbal autopsy exist. 

The coefficients from these regressions and the disaster and collective violence covariates are used to predict excess deaths from these two causes. 

There are reasons, however, to also be concerned that deaths recorded in systems with low coverage may be biased towards selected causes that are more likely to occur in hospital. 

Although at the draw level the same scalar is applied to all causes, the net effect of CoDCorrect is to change the size of more uncertain causes by more than is done for more certain causes, a desirable property.